These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1086622)

  • 1. Clinical, epidemiologic, and pulmonary function studies in alpha,-antitrypsin-deficient subjects of Pi Z type.
    Rawlings W; Kreiss P; Levy D; Cohen B; Menkes H; Brashears S; Permutt S
    Am Rev Respir Dis; 1976 Nov; 114(5):945-53. PubMed ID: 1086622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
    Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
    Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency. Quantitative phenotypes.
    Silverman EK; Province MA; Rao DC; Pierce JA; Campbell EJ
    Am Rev Respir Dis; 1990 Nov; 142(5):1015-21. PubMed ID: 2240821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
    Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
    Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group.
    Turino GM; Barker AF; Brantly ML; Cohen AB; Connelly RP; Crystal RG; Eden E; Schluchter MD; Stoller JK
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1718-25. PubMed ID: 8970361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
    Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
    Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung function studies in asymptomatic individuals with moderately (Pi SZ) and severely (Pi Z) reduced levels of alpha1-antitrypsin.
    Larsson C; Dirksen H; Sundström G; Eriksson S
    Scand J Respir Dis; 1976; 57(6):267-80. PubMed ID: 1087749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors, pulmonary function, and mortality.
    Menkes HA; Cohen BH; Beaty TH; Newill CA; Khoury MJ
    Prog Clin Biol Res; 1984; 147():501-21. PubMed ID: 6610878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease in Yugoslavia.
    Kozarevic D; Laban M; Budimir M; Vojvodic N; Roberts A; Gordon T; McGee DL
    Am Rev Respir Dis; 1978 Jun; 117(6):1039-43. PubMed ID: 307352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships between serum chemotactic factor inactivator, alpha 1-antitrypsin deficiency, and chronic obstructive lung disease.
    Lam S; Chan-Yeung M; Abboud R; Kreutzer D
    Am Rev Respir Dis; 1980 Mar; 121(3):507-12. PubMed ID: 6968167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous alpha-1-antitrypsin deficiency and respiratory function in children.
    Vance JC; Hall WJ; Schwartz RH; Hyde RW; Roghmann KJ; Mudholkar GC
    Pediatrics; 1977 Sep; 60(3):263-72. PubMed ID: 302433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Typologic analysis of comparative effects of tobacco and Pi phenotype on the respiratory function].
    Doré MF; Orvoen-Frija E; Labrousse F; Barrault N; Lebeau B; Jacquemin C
    Bull Eur Physiopathol Respir; 1982; 18(5):717-24. PubMed ID: 6985439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease.
    Sandford AJ; Weir TD; Spinelli JJ; Paré PD
    Am J Respir Cell Mol Biol; 1999 Feb; 20(2):287-91. PubMed ID: 9922220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease and alpha-1-antitrypsin (Pi) variation: a family study.
    Benjamin JJ; Cohen BH; Ball WC; Levy DA; Menkes HA; Kreiss P
    Birth Defects Orig Artic Ser; 1974; 10(4):212-6. PubMed ID: 4549777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function in nonsmoking subjects with alpha1 antitrypsin deficiency (MZ phenotype).
    Gelb AF; Klein E; Lieberman J
    Am J Med; 1977 Jan; 62(1):93-8. PubMed ID: 299981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
    Cox DW; Hoeppner VH; Levison H
    Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community.
    Morse JO; Lebowitz MD; Knudson RJ; Burrows B
    N Engl J Med; 1977 May; 296(21):1190-4. PubMed ID: 300842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction.
    Abboud RT; Rushton JM; Grzybowski S
    Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary abnormalities in intermediate alpha-1-antitrypsin deficiency.
    Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Webb DR; Chaubey YP; Townes PL
    J Clin Invest; 1976 Nov; 58(5):1069-77. PubMed ID: 1086856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological studies in a large sibship with antitrypsin deficiency.
    Duncan PE; Griffin JP
    Br J Dis Chest; 1975 Apr; 69(2):107-17. PubMed ID: 49190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.